NHIA Member Home
Find a Provider

News Category: NHIA News

NHIA Publishes Comments to CMS on Proposed Changes to Immune Globulin HCPCS

  • June 2, 2026
NHIA strongly opposes CMS’s proposed HCPCS coding and billing unit changes for immune globulin products, arguing that the changes would create significant administrative, operational, reimbursement, and patient care challenges without providing meaningful clinical or financial benefit.

NHIF Welcomes New Officers and Board Members

  • May 4, 2026
The National Home Infusion Foundation (NHIF) welcomes the 2026-2027 Board of Directors.

NHIA 2026 Celebrates the Infusion Community & Collaboratively Drives Progress

  • April 29, 2026
Last week concluded the 2026 National Home Infusion Association Annual Conference (NHIA 2026), which convened the largest gathering dedicated to the home and alternate site infusion industry in Denver, Colorado.

NHIA Members Hold 130+ Congressional Meetings in Support of the Preserving Patient Access to Home Infusion Act

November 7, 2025

The National Home Infusion Association (NHIA) today held its annual Advocacy in Action Day, during which association members and patients met with Members of Congress and their staff to advocate for a fix to the Medicare home infusion coverage gap. Over the course of the event, NHIA members held more than 130 meetings in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172 / S. 1058).

Read More »

NHIA Comments on Proposed EIP LCD

September 8, 2025

NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications.

Read More »

Joe Fiandra Access to Home Infusion Act of 2025 (H.R. 4993) Bill Summary

August 25, 2025

The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was first introduced in the House of Representatives in September of 2023, and re-introduced on August 19, 2025 by Rep. Brian Fitzpatrick (PA-01). The bill mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit.

Read More »

NHIA Releases White Paper on Home Parenteral Nutrition Cost Trends

August 5, 2025

The National Home Infusion Association (NHIA) has released a white paper examining the economic challenges facing home parenteral nutrition (HPN) services. The report, “Ensuring Sustainable Access to Home Parenteral Nutrition (PN): The Cost Crisis and Path Forward,” documents cost trends and reimbursement patterns affecting this therapy.

Read More »

Implementation and Pilot Evaluation of A Pharmacist-Led Optimization Tool for Subcutaneous Immune Globulin Administration in the Home Setting

July 31, 2025

Full text | Download pdf

https://doi.org/10.70776/SCYQ3388

Katie Laskin, PharmD, BCSCP, FNHIA, IgCP, CBSC Yale New Haven Health Home Infusion | Jill Yusko, RPh. Yale New Haven Health Home Infusion | Jennifer Bunk, PharmD Yale New Haven Health Home Infusion | Gene B. Decaminada BS Pharm, RPh, FNHIA, FCPA Yale New Haven Health Home Infusion | Nicholas LaRiviere PharmD, MBA, BCGP Yale New Haven Health Home Infusion

This study aimed to develop a standardized method and timeline for home infusion pharmacists to assess subcutaneous immune globulin (SCIG) regimens and perform interventions to optimize infusions based on patient tolerance and preference. A tool was built within the electronic patient management platform at a health system-affiliated home infusion pharmacy to aid in standardizing patient assessments and capturing interventions. This tool was tested over a period of 2 months.

Read More »

A Descriptive Cross-Sectional Study of Patient Experience Among Home Infusion Patients Administering Immune Globulin: A Comparison of Satisfaction Between IV and SC Administration

July 30, 2025

Full text | Download pdf

https://doi.org/10.70776/XISU1319

Danell Haines, PhD Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC National Home Infusion Association

Immune globulin (Ig) preparations are administered to patients to treat a variety of diagnoses. Originally developed to increase and maintain IgG levels in patients with antibody deficiencies, immune globulin preparations are also part of the treatment plan for autoimmune or connective tissue disorders, neurologic diseases, and inflammatory conditions. Due to the growth of Ig therapy in the home, there is a need for more valid and comprehensive patient satisfaction data about the home infusion experience that can be used to improve patient care and outcomes. The objective of this research is to analyze patient satisfaction survey data from the National Home Infusion Foundation and evaluate patient satisfaction similarities and differences between 2 groups: intravenous and subcutaneous administration of immune globulin.

Read More »

Stability of Immune Globulin Intravenous, Human-stwk, 10% Liquid Following Pooling and Storage in Flexible Containers

July 29, 2025

Full text | Download pdf

https://doi.org/10.70776/PNTG6835

Stacey Ness PharmD, IgCP, CSP, MSCS, AAHIVP GC Biopharma USA | Alan Huber BSc Pharm, PharmD, MBA GC Biopharma USA | Suzanne Strasters MSN, FNP-C, IgCN GC Biopharma USA | Nari Ji GC Biopharma Yongin-si, South Korea | JaeWoon Son, PhD. GC Biopharma Yongin-si, South Korea

Immune globulin intravenous, human-stwk, 10% liquid is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. Unopened immune globulin intravenous, human-stwk, 10% liquid in its original container may be stored under refrigerated conditions at (2-8°C/36-46°F) for 36 months or may be stored for 24 months at room temperature (25°C/77°F) from the date it was manufactured. However, pooling intravenous immune globulin from several vials into a single container (usually a flexible bag) under aseptic conditions prior to administration is sometimes desirable in clinical practice.

Read More »

HHS Secretary Kennedy Supports Home Infusion at House E&C Hearing

June 24, 2025

NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.

Read More »

NHIA Comments on MTF for 2026 and 2027

May 1, 2025

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »

NHIA Announces Greg LoPresti to Lead Board of Directors

April 18, 2025

The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.

Read More »

NHIA 2025 Features Largest Home Infusion Expo & Builds a Roadmap for Progress

April 8, 2025

Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Read More »

NHIA Members Hold 130+ Congressional Meetings in Support of the Preserving Patient Access to Home Infusion Act

November 7, 2025

The National Home Infusion Association (NHIA) today held its annual Advocacy in Action Day, during which association members and patients met with Members of Congress and their staff to advocate for a fix to the Medicare home infusion coverage gap. Over the course of the event, NHIA members held more than 130 meetings in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172 / S. 1058).

Read More »

NHIA Comments on Proposed EIP LCD

September 8, 2025

NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications.

Read More »

Joe Fiandra Access to Home Infusion Act of 2025 (H.R. 4993) Bill Summary

August 25, 2025

The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was first introduced in the House of Representatives in September of 2023, and re-introduced on August 19, 2025 by Rep. Brian Fitzpatrick (PA-01). The bill mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit.

Read More »

NHIA Releases White Paper on Home Parenteral Nutrition Cost Trends

August 5, 2025

The National Home Infusion Association (NHIA) has released a white paper examining the economic challenges facing home parenteral nutrition (HPN) services. The report, “Ensuring Sustainable Access to Home Parenteral Nutrition (PN): The Cost Crisis and Path Forward,” documents cost trends and reimbursement patterns affecting this therapy.

Read More »

Implementation and Pilot Evaluation of A Pharmacist-Led Optimization Tool for Subcutaneous Immune Globulin Administration in the Home Setting

July 31, 2025

Full text | Download pdf

https://doi.org/10.70776/SCYQ3388

Katie Laskin, PharmD, BCSCP, FNHIA, IgCP, CBSC Yale New Haven Health Home Infusion | Jill Yusko, RPh. Yale New Haven Health Home Infusion | Jennifer Bunk, PharmD Yale New Haven Health Home Infusion | Gene B. Decaminada BS Pharm, RPh, FNHIA, FCPA Yale New Haven Health Home Infusion | Nicholas LaRiviere PharmD, MBA, BCGP Yale New Haven Health Home Infusion

This study aimed to develop a standardized method and timeline for home infusion pharmacists to assess subcutaneous immune globulin (SCIG) regimens and perform interventions to optimize infusions based on patient tolerance and preference. A tool was built within the electronic patient management platform at a health system-affiliated home infusion pharmacy to aid in standardizing patient assessments and capturing interventions. This tool was tested over a period of 2 months.

Read More »

A Descriptive Cross-Sectional Study of Patient Experience Among Home Infusion Patients Administering Immune Globulin: A Comparison of Satisfaction Between IV and SC Administration

July 30, 2025

Full text | Download pdf

https://doi.org/10.70776/XISU1319

Danell Haines, PhD Research Consultant | Michelle C. Simpson, PharmD, BCSCP, MWC National Home Infusion Association

Immune globulin (Ig) preparations are administered to patients to treat a variety of diagnoses. Originally developed to increase and maintain IgG levels in patients with antibody deficiencies, immune globulin preparations are also part of the treatment plan for autoimmune or connective tissue disorders, neurologic diseases, and inflammatory conditions. Due to the growth of Ig therapy in the home, there is a need for more valid and comprehensive patient satisfaction data about the home infusion experience that can be used to improve patient care and outcomes. The objective of this research is to analyze patient satisfaction survey data from the National Home Infusion Foundation and evaluate patient satisfaction similarities and differences between 2 groups: intravenous and subcutaneous administration of immune globulin.

Read More »

Stability of Immune Globulin Intravenous, Human-stwk, 10% Liquid Following Pooling and Storage in Flexible Containers

July 29, 2025

Full text | Download pdf

https://doi.org/10.70776/PNTG6835

Stacey Ness PharmD, IgCP, CSP, MSCS, AAHIVP GC Biopharma USA | Alan Huber BSc Pharm, PharmD, MBA GC Biopharma USA | Suzanne Strasters MSN, FNP-C, IgCN GC Biopharma USA | Nari Ji GC Biopharma Yongin-si, South Korea | JaeWoon Son, PhD. GC Biopharma Yongin-si, South Korea

Immune globulin intravenous, human-stwk, 10% liquid is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. Unopened immune globulin intravenous, human-stwk, 10% liquid in its original container may be stored under refrigerated conditions at (2-8°C/36-46°F) for 36 months or may be stored for 24 months at room temperature (25°C/77°F) from the date it was manufactured. However, pooling intravenous immune globulin from several vials into a single container (usually a flexible bag) under aseptic conditions prior to administration is sometimes desirable in clinical practice.

Read More »

HHS Secretary Kennedy Supports Home Infusion at House E&C Hearing

June 24, 2025

NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.

Read More »

NHIA Comments on MTF for 2026 and 2027

May 1, 2025

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »

NHIA Announces Greg LoPresti to Lead Board of Directors

April 18, 2025

The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.

Read More »

NHIA 2025 Features Largest Home Infusion Expo & Builds a Roadmap for Progress

April 8, 2025

Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Read More »
News Archive